Equity Awards and Benefits. During the Term, Executive shall be eligible to participate in the Company’s 2017 Equity Incentive Plan or any successor plan as determined by the Board or Compensation Committee and shall be entitled to participate in any benefit plans, including medical, disability and life insurance (but excluding any severance or bonus plans unless specifically referenced in this Agreement) offered by the Company as in effect from time to time (collectively, “Benefit Plans”), on the same basis as those generally made available to other senior executives of the Company, to the extent consistent with applicable law and the terms of the applicable Benefit Plan. The Company does not promise the adoption or continuance of any particular Benefit Plan and reserves the right to amend or cancel any Benefit Plan at any time in its sole discretion (subject to the terms of such Benefit Plan and applicable law).
Equity Awards and Benefits. During the Term, Executive shall be eligible to participate in the Parent’s 2017 Equity Incentive Plan or any amended or successor plan as determined by the Board or Compensation Committee of the Parent. During the Term, Executive shall also be entitled to participate in any benefit plans, including medical, disability and life insurance (but excluding any severance or bonus plans unless specifically referenced in this Agreement) offered by the Company as in effect from time to time (collectively, “Benefit Plans”), on the same basis as those generally made available to other senior executives of the Company, to the extent consistent with applicable law and the terms of the applicable Benefit Plan. The Company does not promise the adoption or continuance of any particular Benefit Plan and reserves the right to amend or cancel any Benefit Plan at any time in its sole discretion (subject to the terms of such Benefit Plan and applicable law).
Equity Awards and Benefits. As soon as reasonably practicable following the Effective Date, subject to approval by the Board, Executive or his designees shall be granted 8,400,000 restricted stock units pursuant to the Company’s 2018 Omnibus Incentive Plan or such other or successor plan then established by Company Executive shall also be entitled to an award of 3,150,000 restricted stock units following an initial public offering involving the common stock of the Company or the consummation of a transaction in which the common stock of the Company is converted into shares of an entity that is publicly traded on a national securities exchange. In addition, on an annual basis the Board shall conduct an annual performance review of Executive pursuant to which Executive shall have the opportunity to earn an additional annual grant of up to 1,000,000 additional restricted stock units subject to achievement of certain performance metrics established by the Board of Directors in the Board’s discretion which metrics shall include the Company’s performance with respect to environmental, social and governance practices, improvements with respect to sustainability in the Company’s business operations as well as such other business operational performance as the Board of Directors may establish. Restricted stock units granted to Executive hereunder or during the term of Executive’s employment shall be issued pursuant to the Company’s 2018 Omnibus Incentive Plan or such other successor plan established by Company (as amended from time to time, the “Plan”) or otherwise as the Board shall determine in its discretion. Equity awards granted to Executive or his designees shall have such terms, conditions and vesting set forth in the applicable award agreement issued pursuant to the Plan the form of which is attached as Exhibit A. Notwithstanding the foregoing, equity awards granted to Executive during the term of his employment shall fully vest if Executive’s employment is terminated as a result of Executive’s death or “Disability” (as defined in Section 8(b) hereof, or by Company without “Cause” (as defined in Section 10(a) hereof) or for “Good Reason” (as defined in Section 10(c) hereof).
Equity Awards and Benefits. Immediately prior to the effective date of the merger with and into XPDI pursuant to the Agreement and Plan of Merger dated July 20, 2021, subject to approval by the Board, Executive shall be granted options to purchase 5,000,000 shares of common stock of the Company pursuant to the Company’s 2018 Omnibus Incentive Plan or such other or successor plan then established by Company Options granted to Executive hereunder or during the term of Executive’s employment shall be issued pursuant to the Company’s 2018 Omnibus Incentive Plan or such other successor plan established by Company (as amended from time to time, the “Plan”) or otherwise as the Board shall determine in its discretion. Equity awards granted to Executive or his designees shall have such terms, conditions and vesting set forth in the applicable award agreement issued pursuant to the Plan. Notwithstanding the foregoing, equity awards granted to Executive hereunder shall fully vest if Executive’s employment is terminated as a result of Executive’s death or “Disability” (as defined in Section 8(b) hereof, or by Company without “Cause” (as defined in Section 10(a) hereof) or for “Good Reason” (as defined in Section 10(c) hereof).
Equity Awards and Benefits. (a) So long as this Agreement remains in full force and effect, and subject to approval by the Board of Managers of Forma Therapeutics Holdings, LLC or an appropriate committee appointed by the Board of Managers and pursuant to a written stock award agreement (the “Award Agreement), entered into by and between the Employee and Forma Therapeutic Holdings, LLC pursuant to the Equity Plan (the “Plan’), the Employee shall be granted 288,000 shares of each of Forma Therapeutics Holdings, LLC, Common 5 Shares, Common 6 shares and Common 7 Shares (collectively, the “Award”). The terms and conditions of the Award will be as set forth in the Plan and the Award Agreement. The Employee’s Award will vest in accordance with the Company’s Award Agreement, including vesting over four (4) years with 25% vesting after the first year and the remainder vesting monthly thereafter.
